Introduced by Rep. Lisa Brown (D) on February 16, 2010, to include N-benzylpiperazine as a schedule 1 controlled substance, meaning it would be in the same illegal drug category as cocaine, methamphetamine, heroin, LSD, marijuana, etc. N-benzylpiperazine reportedly has effects similar to amphetamines.
Referred to the House Health Policy Committee on February 16, 2010.
Reported in the House on March 9, 2010, with the recommendation that the substitute (H-1) be adopted and that the bill then pass.